HM1.24/BST-2 is constitutively poly-ubiquitinated at the N-terminal amino acid in the cytoplasmic domain
HM1.24/BST-2 is constitutively poly-ubiquitinated at the N-terminal amino acid in the cytoplasmic domain
复制标题
HM1.24/BST-2 在胞质结构域的 N 末端氨基酸处被组成型多泛素化
DOI:
10.1016/j.bbrep.2020.100784
复制
发表时间:
2020
影响因子:
2.7
通讯作者:
Tanaka Yoshitaka
中科院分区:
文献类型:
--
作者:
Fujimoto Keiko;Nakashima Sanae;Uchida Shotaro;Amen Riham N.S.;Ishii Yuji;Hirota Yuko;Tanaka Yoshitaka
HM1.24 (also known as BST-2, CD317, and Tetherin) is a type II single-pass transmembrane glycoprotein, which traverses membranes using an N-terminal transmembrane helix and is anchored in membrane lipid rafts via a C-terminal glycosylphosphatidylinositol (GPI). HM1.24 plays a role in diverse cellular functions, including cell signaling, immune modulation, and malignancy. In addition, it also functions as an interferon-induced cellular antiviral restriction factor that inhibits the replication and release of diverse enveloped viruses, and which is counteracted by Vpu, an HIV-1 accessory protein. Vpu induces down-regulation and ubiquitin conjugation to the cytoplasmic domain of HM1.24. However, evidence for ubiquitination site(s) of HM1.24 remains controversial. We demonstrated that HM1.24 is constitutively poly-ubiquitinated at the N-terminal cytoplasmic domain, and that the mutation of all potential ubiquitination sites, including serine, threonine, cysteine, and lysine in the cytoplasmic domain of HM1.24, does not affect the ubiquitination of HM1.24. We further demonstrated that although a GPI anchor is necessary and sufficient for HM1.24 antiviral activities and virion-trapping, the deleted mutant of GPI does not influence the ubiquitination of HM1.24. These results suggest that the lipid raft localization of HM1.24 is not a prerequisite for the ubiquitination. Collectively, our findings demonstrate that the ubiquitination of HM1.24 occurs at the N-terminal amino acid in the cytoplasmic domain and indicate that the constitutive ubiquitination machinery of HM1.24 may differ from the Vpu-induced machinery.
登录
查看更多内容
影响因子:
30.3
作者:
Hinz A;Miguet N;Natrajan G;Usami Y;Yamanaka H;Renesto P;Hartlieb B;McCarthy AA;Simorre JP;Göttlinger H;Weissenhorn W
通讯作者:
Weissenhorn W
DOI:
--
发表时间:
2010
期刊:
Drug Metab. Dispos.
影响因子:
--
作者:
Amano J.;Masuyama N.;Hirota Y.;Tanaka Y.;Igawa Y.;Shiokawa R.;Okutani T.;Miyayama T.;Nanami M.;and Ishigai M.
通讯作者:
and Ishigai M.
影响因子:
11.2
作者:
Jennifer Walter-Yohrling;Xiaohong Cao;Michele Callahan;W. Weber;S. Morgenbesser;S. Madden;Clarence J. Wang;B. Teicher
通讯作者:
Jennifer Walter-Yohrling;Xiaohong Cao;Michele Callahan;W. Weber;S. Morgenbesser;S. Madden;Clarence J. Wang;B. Teicher
影响因子:
20.3
作者:
Tetsuya Goto;Stephen J. Kennel;Masahiro Abe;Makoto Takishita;Masaaki Kosaka;Alan Solomon;Shiro Saito-S
通讯作者:
Tetsuya Goto;Stephen J. Kennel;Masahiro Abe;Makoto Takishita;Masaaki Kosaka;Alan Solomon;Shiro Saito-S
影响因子:
7.5
作者:
Piper, Robert C.;Luzio, J. Paul
通讯作者:
Luzio, J. Paul